Giordano Natasha
SEC-identified person · CIK 1315585 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Oragenics INC orni | Director | filed 2025–2025 |
| Matinas Biopharma Holdings, Inc. MTNB] | Director | filed 2020–2023 |
| PLx Pharma Inc. PLXP | Director · President and CEO | filed 2017–2022 |
| Aceto Corp ACETQ | Director | filed 2011–2019 |
| Selway Capital Acquisition Corp. SWCAU | Director · CEO and President | filed 2014–2014 |
| Dendrite International INC DRTE | Senior Vice President | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.